NASDAQ: TIVCTivic Health Systems Inc Stock
$0.25+0.00 (+0%)
Updated Dec 6, 2024
TIVC Price
$0.25
Fair Value Price
N/A
Market Cap
$2.08M
52 Week Low
$0.22
52 Week High
$2.24
P/E
-0.19x
P/B
0.74x
P/S
1.62x
PEG
N/A
Dividend Yield
N/A
Revenue
$957.00k
Earnings
-$6.42M
Gross Margin
25.7%
Operating Margin
-670.95%
Profit Margin
-671%
Debt to Equity
0.2
Operating Cash Flow
-$6M
Beta
0.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
TIVC Overview
Tivic Health Systems Incorporated is a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, a medical device intended to relieve sinus and nasal inflammation. The company sells its products through its own website and other online retailers. Tivic Health Systems was incorporated in 2016 and is headquartered in Hayward, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine TIVC's potential to beat the market
- TIVC doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important TIVC news, forecast changes, insider trades & much more!
TIVC News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TIVC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TIVC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TIVC is good value based on its book value relative to its share price (0.74x), compared to the US Medical Devices industry average (4.05x)
P/B vs Industry Valuation
TIVC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TIVC due diligence checks available for Premium users.
Valuation
TIVC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.19x
Industry
36.83x
Market
29.86x
TIVC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.74x
Industry
4.05x
TIVC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TIVC's financial health
Profit margin
Revenue
$126.0k
Net Income
-$1.4M
Profit Margin
-1,135.7%
TIVC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TIVC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.4M
Liabilities
$560.0k
Debt to equity
0.2
TIVC's short-term assets ($3.16M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TIVC's short-term assets ($3.16M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TIVC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.4M
Investing
$0.0
Financing
-$97.0k
TIVC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
TIVC vs Medical Device Stocks
Tivic Health Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.